Jerald Radich

Faculty Highlight: Dr. Jerald Radich

Binaytara Foundation

Dr. Jerald Radich on Impact of Generic Imatinib in CML

Jerald Radich, MD, Recognizes International CML Day

Blood Cancers Today

Dr. Jerald P. Radich on Treatment Considerations with Generic Imatinib in CML

Dr. Radich on the Potential of Biosimilars in Oncology

Surviving Cancer: The Biology of Luck | Jerry Radich | TEDxSeattle

Knowledge Centre: When to Consider Allogenic Transplantation

International CML Foundation

Dr. Radich on Measuring MRD in Hematologic Malignancies

The molecular complexity of CML

VJHemOnc – Video Journal of Hematology & HemOnc

Myeloid Leukemias: A Model for Molecular Diagnostics and Targeted Cancer Therapy - Jerald Radich, MD

Dr Jerald Radich and Gail Sperling Leukemia and Lymphoma Society of Physicians And Patients

WOCA The Source Radio

Using rapid NGS testing for trial assignment in the NCI precision medicine initiative in AML and MDS

Dr. Jerry Radich on predicting and preventing relapse - Fred Hutch Science for Life

Myeloid Leukemias: A Model for Molecular Diagnostics and Targeted Cancer Therapy - Jerald Radich, MD

Knowledge Centre - From the Lab - Non-Clinical - New Ways to Improve Molecular Analysis

International CML Foundation

ENESTnd: results from an exploratory biomarker analysis in CML

VJHemOnc – Video Journal of Hematology & HemOnc

Copy of Dr. Radich on the Potential of Biosimilars in Oncology

Dr. Radich on Compliance to NCCN Guidelines in CML

Dr. Radich on Treatment Discontinuation in CML Off Trial

Jerry Radich Cancer Ecosystem